Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2021 / Articles / Dec / 2021 in Review: Our Best Videos
Business & Regulation Advanced Medicine Vaccines Standards & Regulation COVID-19 Regulation & Standards Business & Trends

2021 in Review: Our Best Videos

Another year of the pandemic; another year of Zoom calls

By Angus Stewart 12/24/2021 1 min read Quick Read (pre 2022)

Share

The editors of The Medicine Maker aren’t just writers. We’re Zoom pros too! Put your feet up and bask in some of the content we have created over the past year. Here are our top five editorial videos, featuring our very favourite experts and interviewees.

Cell and gene therapy can revolutionize medicine, but first it needs infrastructure. In the UK, that’s exactly what the Cell and Gene Therapy Catapult is working to create. In parts one and two of this in-depth interview, the Catapult’s Chief Business Officer Sharon Brownlow spoke to us about the pivotal role she played in securing collaborative research funding with partners, and supporting the growth and productivity of the field.

NanoSyrinx is a discovery-stage synthetic biology biotech developing a novel delivery modality for complex biologics. In Part 1 of this interview we spoke to its founder, Joe, about his career and the story behind this exciting young company. In Part 2, Joe discusses the major trends in the cell and gene therapy space, the ins and outs of investment, and what the future holds.

Mike Rea is a man with opinions. In his chat with Stephanie, our fearless lead editor, Mike breaks down why the conventional wisdom behind drug launches and positioning is completely back to front. It is time to cast out the oracles. Watch, and you will understand. (Alternatively, you can read this interview in Q&A form HERE.)

Our 2020 Power List set the bar high – so high that picking the champions of our 2022 list will prove no mean feat. For this video, we rallied four pharma thought leaders for a back and forth on the pandemic and what it means for the future of the industry. Note that we uploaded this conversation back in January 2021 – so consider this video a portal back in time to an earlier stage in the evolution of the pandemic!

Speaking of journeys back in time, we admit we are cheating slightly here. This digital roundtable featuring Adrian Wildfire, Rebecca Cox, Marco Cavaleri, Daniel Hoft, and Pieter Neels went up to our channel in December 2020, but the insights were so rich that we simply had to include it in this list.

That’s all for our Youtube year-in-review. Want to suggest topics for future videos? Want to offer yourself up as an interviewee? We’re all ears, so drop us an email here: angus.stewart@texerepublishing.com

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Angus Stewart

Between studying for my English undergrad and Publishing master's degrees I was out in Shanghai, teaching, learning, and getting extremely lost. Now I'm expanding my mind down a rather different rabbit hole: the pharmaceutical industry. Outside of this job I read mountains of fiction and philosophy, and I must say, it's very hard to tell who's sharper: the literati, or the medicine makers.

More Articles by Angus Stewart

False

Advertisement

Recommended

False

Related Content

Don’t Forget CDx Developers
Advanced Medicine
Don’t Forget CDx Developers

November 7, 2014

0 min read

Many drug developers are going ‘full steam ahead’ with personalized medicine strategies. They would be wise to consider a more equitable business model for an essential partner in the process: the developer of the companion diagnostic.

The Next Decade of Cell and Gene Therapies
Advanced Medicine Bioprocessing - Upstream & Downstream Trends & Forecasts Digital Technologies
The Next Decade of Cell and Gene Therapies

May 7, 2025

5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.

Peter Marks Resigns from FDA
Standards & Regulation Profession Vaccines Advanced Medicine
Peter Marks Resigns from FDA

April 1, 2025

3 min read

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr. “Rather he wishes subservient confirmation of his misinformation and lies.”

The Trump Effect on Cell and Gene: Science versus Shockwaves
Business Practice Standards & Regulation Trends & Forecasts Advanced Medicine
The Trump Effect on Cell and Gene: Science versus Shockwaves

April 1, 2025

9 min read

Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.